Liu Benjin, Li Shangjian, Xu Yisi, Huang Xuqi, Guo Xudong, Wang Hanbo, Jiang Shaobo
Department of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Discov Oncol. 2025 Jul 10;16(1):1297. doi: 10.1007/s12672-025-03141-7.
Although hemangiomas frequently occur in the skin, mucosa, liver, and brain, they are rarely observed in the abdominal cavity or retroperitoneum. Moreover, the expression of the somatostatin receptor (SSTR), a member of the G protein-coupled receptor superfamily, in hemangiomas is an uncommon phenomenon. Here, we report the case of a patient with hemangioma expressing somatostatin receptors. To date, this is the second documented case of multiple hemangiomas in which somatostatin receptors are expressed (Chua et al. Clin Nucl Med 47:321-323, 2022; Müssig et al. J Clin Endocrinol Metab 94:4123-4124, 2009).
A 66-year-old female with normal blood pressure and occasional episodes of hypertension but no symptoms, such as headache, chest pain, or palpitations, was found to have multiple hypervascular lesions in the retroperitoneum, rectouterine pouch, abdominal wall, and small bowel wall on pelvic contrast-enhanced CT. On the basis of the imaging findings from the CT and PET scans, the initial diagnosis was metastatic paraganglioma. The patient underwent laparoscopic surgery, and the tumors in the retroperitoneum and abdominal wall were successfully removed. Histopathological diagnosis confirmed hemangioma. Immunohistochemistry revealed positive expression of the endothelial cell markers CD31(+) and CD34(+), as well as expression of somatostatin receptor 2 (SSTR2), in some cytoplasmic cells.
This case highlights the rare expression of somatostatin receptors in hemangiomas, which may provide insights into their biological behavior and potential therapeutic targets. Increased awareness of such atypical presentations can improve diagnostic accuracy and inform clinical management strategies.
尽管血管瘤常发生于皮肤、黏膜、肝脏和脑,但在腹腔或腹膜后很少见。此外,作为G蛋白偶联受体超家族成员的生长抑素受体(SSTR)在血管瘤中的表达是一种不常见的现象。在此,我们报告一例表达生长抑素受体的血管瘤患者。迄今为止,这是第二例有记录的表达生长抑素受体的多发性血管瘤病例(Chua等人,《临床核医学》47:321 - 323,2022;Müssig等人,《临床内分泌与代谢杂志》94:4123 - 4124,2009)。
一名66岁女性,血压正常,偶发高血压,无头痛、胸痛或心悸等症状,盆腔增强CT检查发现腹膜后、直肠子宫陷凹、腹壁和小肠壁有多个高血运病变。根据CT和PET扫描的影像学表现,初步诊断为转移性副神经节瘤。患者接受了腹腔镜手术,成功切除了腹膜后和腹壁的肿瘤。组织病理学诊断证实为血管瘤。免疫组化显示内皮细胞标志物CD31(+)和CD34(+)呈阳性表达,并且在一些细胞质细胞中生长抑素受体2(SSTR2)也有表达。
本病例突出了生长抑素受体在血管瘤中的罕见表达,这可能为其生物学行为和潜在治疗靶点提供见解。提高对这种非典型表现的认识可提高诊断准确性并为临床管理策略提供依据。